SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 61 filers reported holding SUTRO BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,861 | -85.1% | 20,421 | -80.1% | 0.00% | -83.3% |
| Q2 2023 | $476,848 | -43.6% | 102,548 | -43.9% | 0.01% | -47.8% |
| Q1 2023 | $844,832 | -32.2% | 182,864 | +18.6% | 0.02% | -34.3% |
| Q4 2022 | $1,245,984 | +288.2% | 154,206 | +166.5% | 0.04% | +218.2% |
| Q3 2022 | $321,000 | +53.6% | 57,869 | +312.1% | 0.01% | -15.4% |
| Q4 2021 | $209,000 | -17.4% | 14,041 | -56.9% | 0.01% | -27.8% |
| Q2 2020 | $253,000 | +125.9% | 32,601 | +219.1% | 0.02% | +157.1% |
| Q4 2019 | $112,000 | – | 10,215 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |